Long-term effect and risk factors of allogeneic vein replacement in borderline resectable pancreatic cancer
10.3760/cma.j.cn113884-20220302-00079
- VernacularTitle:同种异体静脉在交界可切除胰腺癌中应用的效果及管腔狭窄危险因素分析
- Author:
Shaocheng LYU
1
;
Qiang HE
;
Ren LANG
;
Hua FAN
;
Lixin LI
;
Xianliang LI
;
Jiantao KOU
;
Yu LIU
Author Information
1. 首都医科大学附属北京朝阳医院肝胆外科，北京 100020
- Keywords:
Pancreatic neoplasms;
Pancreatectomy;
Prognosis;
Vascular invasion;
Allogeneic vessel;
Stenosis
- From:
Chinese Journal of Hepatobiliary Surgery
2022;28(8):576-581
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the effect of allogenic vein replacement in treatment of borderline resectable pancreatic cancer, and to analyze risk factors of long-term stenosis.Methods:The clinical data of 77 patients with borderline resectable pancreatic cancer who underwent surgery from January 2013 to December 2021 at the Beijing Chaoyang Hospital, Capital Medical University were retrospectively analyzed. There were 34 males and 43 females, aged (61.4±10.8) years old. The peri-operative data, long-term prognosis and stenosis of allogenic vein were analysed. Risk factors of stenosis were analyzed by the Cox proportional hazards model. Patients were followed up by outpatient visits or by telephone.Results:Pancreatic cancer had invaded the junction of portal vein/superior mesenteric vein (SMV) in 41 patients, SMV in 22 patients and portal vein in 14 patients. The length of venous resection was (3.7±1.0) cm, the tumor longest diameter was (3.8±1.6) cm, lymph node metastasis was present in 57 patients, R 0 resection was carried out in 70 patients, and the postoperative complication rate was 29.9% (23/77). The survival rates in 6 months, 1-year and 2-year were 84.1%, 52.3% and 32.9% respectively. Mild venous stenosis occurred in 4 patients (5.2%), moderate stenosis in 9 patients (11.7%) and severe stenosis in 11 patients (14.3%). A vascular resection length of more than 3 cm ( RR=4.602, 95% CI: 1.657-12.781, P=0.003) and tumor recurrence ( RR=8.529, 95% CI: 1.129-64.448, P=0.038) were independent risk factors for long-term moderate and severe stenosis of allogeneic vein. Conclusion:It was safe and feasible for allogenic vein to be used to reconstruct the portal venous system in resection of borderline resectable pancreatic cancer. Long-term stenosis of the allogenic vein was related to a length of vascular resection of more than 3 cm and recurrence of tumor.
